Refine by
Patient Data Articles & Analysis
458 news found
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM, OTCQB: HMTXF; FSE:2VF0), the leading autologous (patient’s own) stem cell therapy company treating no-option patients in Florida suffering in pain from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease and Angina, is pleased to announce its webinar topic for Thursday, August 21, 2025. Croom ...
Summary Did you know that between 64% and 93% of dentists and dental hygienists experience work-related musculoskeletal pain?1 The solution to working pain-free might lie in better ergonomics education. Ergonomics is vital in dentistry, where professionals often work in static, awkward positions that can lead to musculoskeletal disorders and chronic pain. Proper ergonomic practices can help ...
The Company first achieved its ISO/IEC 27001 certification in 2014, demonstrating a robust information security management system was implemented to handle customer data securely. These internationally recognized standards, developed and published by the world’s most recognized standards organization for information security management systems, underscore the ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, will unveil new research at the European Society for Medical Oncology (ESMO) 2024. ...
As more hospitals and labs go into routine, SOPHiA GENETICS and AstraZeneca, in collaboration with leading cancer institutes within the SOPHiA GENETICS community, will generate a vast set of real-world data from patients around the world with a variety of cancers. This data set has the potential to generate unique insights towards advancing ...
Since launching the first generation of SOPHiA DDM™ in 2015, the Platform has been at the forefront of these innovations, accelerating the practice of data driven medicine globally as a leading platform in healthcare for using data to improve patient care. ...
“We are excited to see how Modus Plan can improve the precision of brain surgeries and enhance patient outcomes,” said Cameron Piron, Chief Strategy Officer, President, and Cofounder of Synaptive Medical. ...
Cameron shares invaluable leadership and entrepreneurial insights, reflecting on the journey of founding and growing Synaptive globally, how he leverages artificial intelligence to enhance surgical outcomes and streamline medical procedures, and the importance of data collection in improving patient care and surgical precision. Click the link to listen to this ...
Currently, ~30-40% of eligible NSCLC patients do not receive appropriate testing1. In September 2023, Tempus and AstraZeneca initiated a pilot program to leverage Next to identify this specific care gap at participating provider sites, using AI to scan unstructured clinical data to understand which patients may be eligible for testing based on ...
ByTempus
At the 2024 ASCO® Annual Meeting, the company is presenting new data on the xM test with an analytically improved pipeline. The research demonstrates a clinical sensitivity at a landmark of 61.1% and a robust surveillance performance with longitudinal sensitivity of 83.3% and specificity of 89.5% across stage II/III CRC patients. xM MRD results predict ...
ByTempus
Prophecy Market Research says it could reach US$ 508.7 billion by 2034. From data to diagnostics and imaging, drug development and discovery, early intervention and predictive analytics, remote patient monitoring and robotics, AI is revolutionizing healthcare as we know it. ...
Longeveron's foundation in cutting-edge cellular therapy research, coupled with the promise of Lomecel-BTM, positions us to profoundly impact patients' lives for the better by addressing numerous unmet medical needs with U.S. market potential opportunities of up to approximately $10-$18 billion. ...
As we look into the new year, the healthcare landscape in the UK is undergoing a number of changes. From digital transformation to evolving regulations, healthcare organisations across the UK are facing a number of challenges in 2024. We delve into five potential challenges confronting healthcare providers across the UK to help them prepare for the year ahead. ...
Caresyntax CDaaS helps partners overcome the opacity that surrounds the patient experience in the OR. While modern electronic medical records (EMR) and data warehouses provide insight to high level data like demographics, billing, and reimbursement claims, there is less discrete data output from the actual OR experience. ...
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS partners that provide software solutions that run on or integrate with AWS. ...
This method uses state-of-the-art instruments that precisely measure key flow properties, including the angle of repose, bulk density, and flow rate. By obtaining accurate data on these parameters, CD Formulation aims to empower pharmaceutical companies to optimize their formulation processes. ...
It can aid in the diagnosis of asthma and COPD and can also help identify patients who are at risk of progression to COPD. [1] The tremoflo® C-100 assesses respiratory function through simple tidal breathing and can be a valuable tool when compiling a detailed picture of respiratory function. It is particularly useful in enabling the very young, frail, or ...
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, taking place in Washington. ...
Picosecond laser technology is a highly sought-after treatment in the field of medical aesthetics that can effectively treat all types of skin blemishes. The treatment of blemishes has long been one of the most difficult problems in the field of medical aesthetics and with the use of picosecond laser technology, there is finally a simple and effective solution to this problem. Bvlaser is a ...